Jefferies Financial Group Inc. Supernus Pharmaceuticals, Inc. Transaction History
Jefferies Financial Group Inc.
- $15.9 Billion
- Q4 2024
A detailed history of Jefferies Financial Group Inc. transactions in Supernus Pharmaceuticals, Inc. stock. As of the latest transaction made, Jefferies Financial Group Inc. holds 24,600 shares of SUPN stock, worth $794,334. This represents 0.01% of its overall portfolio holdings.
Number of Shares
24,600
Previous 24,600
-0.0%
Holding current value
$794,334
Previous $889,000
-0.0%
% of portfolio
0.01%
Previous 0.01%
Shares
4 transactions
Others Institutions Holding SUPN
# of Institutions
303Shares Held
60.7MCall Options Held
22.3KPut Options Held
6K-
Black Rock Inc. New York, NY10.4MShares$336 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.15MShares$199 Million0.0% of portfolio
-
Armistice Capital, LLC New York, NY4.84MShares$156 Million2.47% of portfolio
-
Dimensional Fund Advisors LP Austin, TX2.88MShares$92.9 Million0.03% of portfolio
-
Macquarie Group LTD Australia, C32.63MShares$84.9 Million0.11% of portfolio
About SUPERNUS PHARMACEUTICALS, INC.
- Ticker SUPN
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 53,495,300
- Market Cap $1.73B
- Description
- Supernus Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of products for the treatment of central nervous system (CNS) diseases in the United States. Its commercial products are Trokendi XR, an extended release topiramate product indicated for the treatment of epilepsy, as well as for the prop...